Septerna, Inc.
NASDAQ:SEPNBiotechnology
-$0.73 today
- Market cap
- $1.88B
- Beta
- 2.38
- P/E (TTM)
- -43.6
- EPS (TTM)
- -$0.81
Volume 0.30M
Average 0.32M
SEPN Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Septerna, Inc.NASDAQ: SEPN
Total Assets · Q3 FY2026 · quarter ended Sep 2026
Total assets rises 2.1% from a year ago
Total assets stood at $619.4M at the end of Q3 FY2026, up 2.1% from a year earlier and up 9.3% from the prior quarter. Over 3 fiscal years it compounded at +154.6% a year.
Context
- Total assets increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps rising in the next quarterly balance sheet after a +2.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 596.19M USD
- Year-over-year change
- +30.6%
- 3-year CAGR
- +154.6%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 596.19M | +30.6% |
| FY2024 | 2024-12-31 | 456.55M | +248.9% |
| FY2023 | 2023-12-31 | 130.87M | +262.3% |
| FY2022 | 2022-12-31 | 36.12M | — |
Total Assets vs competitors
How SEPN compares with its peers on the latest reported figures
- SEPN's Sep 2026 total assets of $619.4M is the 3rd highest of the 7 companies compared; the peer median is $460.16M.
- Its year-over-year change of +2.1% is the 5th highest of 6, against a peer median of +26.1%.
- Over three fiscal years its annual growth of +154.6% compares with a peer median of +39.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Jun 2026 | $1.43B | +74.6% | +153.0% | |
KLRAKailera Therapeutics, Inc. | Jun 2026 | $1.21B | — | — |
SEPNSepterna, Inc. | Sep 2026 | $619.4M | +2.1% | +154.6% |
MBXMBX Biosciences, Inc. Common Stock | Sep 2026 | $500.62M | +25.1% | +104.4% |
| Mar 2026 | $419.71M | +26.1% | +38.4% | |
| Mar 2026 | $98.81M | +208.5% | +39.3% | |
| Mar 2026 | $46.39M | -15.7% | -23.2% | |
| Peer median (excluding SEPN) | $460.16M | +26.1% | +39.3% | |
Competitors are the stored peer set for SEPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Septerna, Inc.
NASDAQ:SEPN
Intrinsic Alpha fair value
Locked
Current Price
$39.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.